These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 21422817)

  • 21. HDV-like self-cleaving ribozymes.
    Webb CH; Lupták A
    RNA Biol; 2011; 8(5):719-27. PubMed ID: 21734469
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro selection analysis of trans-acting HDV ribozyme.
    Nishikawa F; Chiba A; Shirai M; Fauzi H; Taira K; Kumar PK; Nishikawa S
    Nucleic Acids Symp Ser; 1995; (34):115-6. PubMed ID: 8841579
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An AU at the first base pair of helix 3 elevates the catalytic activity of hepatitis delta virus ribozymes.
    Huang ZS; Ping YH; Wu HN
    FEBS Lett; 1997 Aug; 413(2):299-303. PubMed ID: 9280301
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficient inhibition of hepatitis B virus replication by hammerhead ribozymes delivered by hepatitis delta virus.
    Li X; Kuang E; Dai W; Zhou B; Yang F
    Virus Res; 2005 Dec; 114(1-2):126-32. PubMed ID: 16054262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Delta ribozyme has the ability to cleave in transan mRNA.
    Roy G; Ananvoranich S; Perreault JP
    Nucleic Acids Res; 1999 Feb; 27(4):942-8. PubMed ID: 9927724
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Investigation on activities of hammerhead ribozyme embedded in genomic RNA of hepatitis delta virus].
    Li XJ; Kuang ES; Dai W; Yang FH; Wang M; Wang HS; Zhou BP
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Mar; 19(1):12-5. PubMed ID: 16201462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Reconstruction of hepatitis D virus ribozymes and their ability to trans-cleave hepatitis C virus RNA].
    Yu Y; Mao Q; Li Q; Wang Y; Min F
    Zhonghua Gan Zang Bing Za Zhi; 2001 Jun; 9(3):157-9. PubMed ID: 11412391
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synergistic stimulation of HIV-1 rev-dependent export of unspliced mRNA to the cytoplasm by hnRNP A1.
    Najera I; Krieg M; Karn J
    J Mol Biol; 1999 Feb; 285(5):1951-64. PubMed ID: 9925777
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High level inhibition of HIV replication with combination RNA decoys expressed from an HIV-Tat inducible vector.
    Fraisier C; Irvine A; Wrighton C; Craig R; Dzierzak E
    Gene Ther; 1998 Dec; 5(12):1665-76. PubMed ID: 10023446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and mode of action of hammerhead and hairpin ribozymes against various HIV-1 target sites.
    Hotchkiss G; Maijgren-Steffensson C; Ahrlund-Richter L
    Mol Ther; 2004 Jul; 10(1):172-80. PubMed ID: 15233952
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of protein partners of the human immunodeficiency virus 1 tat/rev exon 3 leads to the discovery of a new HIV-1 splicing regulator, protein hnRNP K.
    Marchand V; Santerre M; Aigueperse C; Fouillen L; Saliou JM; Van Dorsselaer A; Sanglier-Cianférani S; Branlant C; Motorin Y
    RNA Biol; 2011; 8(2):325-42. PubMed ID: 21368586
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiviral effects of human immunodeficiency virus type 1-specific small interfering RNAs against targets conserved in select neurotropic viral strains.
    Dave RS; Pomerantz RJ
    J Virol; 2004 Dec; 78(24):13687-96. PubMed ID: 15564478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ribozyme-mediated suppression of Moloney murine leukemia virus and human immunodeficiency virus type I replication in permissive cell lines.
    Sun LQ; Warrilow D; Wang L; Witherington C; Macpherson J; Symonds G
    Proc Natl Acad Sci U S A; 1994 Oct; 91(21):9715-9. PubMed ID: 7937878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel mono- and di-DNA-enzymes targeted to cleave TAT or TAT-REV RNA inhibit HIV-1 gene expression.
    Unwalla H; Banerjea AC
    Antiviral Res; 2001 Aug; 51(2):127-39. PubMed ID: 11431037
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HDV ribozymes.
    Been MD
    Curr Top Microbiol Immunol; 2006; 307():47-65. PubMed ID: 16903220
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of HIV-1 replication by targeting the Rev protein.
    Nakaya T; Iwai S; Fujinaga K; Otsuka E; Ikuta K
    Leukemia; 1997 Apr; 11 Suppl 3():134-7. PubMed ID: 9209321
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A chimeric human immunodeficiency virus type 1 (HIV-1) minimal Rev response element-ribozyme molecule exhibits dual antiviral function and inhibits cell-cell transmission of HIV-1.
    Yamada O; Kraus G; Luznik L; Yu M; Wong-Staal F
    J Virol; 1996 Mar; 70(3):1596-601. PubMed ID: 8627679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanistic analysis of the hepatitis delta virus (HDV) ribozyme: methods for RNA preparation, structure mapping, solvent isotope effects, and co-transcriptional cleavage.
    Chadalavada DM; Cerrone-Szakal AL; Wilcox JL; Siegfried NA; Bevilacqua PC
    Methods Mol Biol; 2012; 848():21-40. PubMed ID: 22315061
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of an HDV ribozyme which consists of three RNA oligomer strands.
    Sakamoto T; Kuwabara T; Tanaka Y; Kurihara Y; Katahira M; Uesugi S
    Nucleic Acids Symp Ser; 1995; (34):131-2. PubMed ID: 8841587
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suppression of HIV-1 replication by a combination of endonucleolytic ribozymes (RNase P and tRNnase ZL).
    Ikeda M; Habu Y; Miyano-Kurosaki N; Takaku H
    Nucleosides Nucleotides Nucleic Acids; 2006; 25(4-6):427-37. PubMed ID: 16838836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.